Joerg Krueger

7.7k total citations
59 papers, 463 citations indexed

About

Joerg Krueger is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joerg Krueger has authored 59 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 22 papers in Oncology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joerg Krueger's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Lymphoblastic Leukemia research (17 papers) and CAR-T cell therapy research (13 papers). Joerg Krueger is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Lymphoblastic Leukemia research (17 papers) and CAR-T cell therapy research (13 papers). Joerg Krueger collaborates with scholars based in Canada, United States and Israel. Joerg Krueger's co-authors include Tal Schechter, Muhammad Ali, Adam Gassas, Donna A. Wall, R. Maarten Egeler, Hisaki Fujii, Susan E. Richardson, Jason D. Pole, Mohammed Al Essa and Paul C. Nathan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Joerg Krueger

57 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joerg Krueger Canada	12	192	154	103	77	75	59	463
Kamille A. West United States	13	159 0.8×	124 0.8×	64 0.6×	81 1.1×	71 0.9×	43	480
Yifei Cheng China	15	256 1.3×	404 2.6×	123 1.2×	55 0.7×	87 1.2×	81	630
Eiko Hayase Japan	13	162 0.8×	169 1.1×	121 1.2×	30 0.4×	177 2.4×	31	502
Fabio Giglio Italy	14	308 1.6×	402 2.6×	338 3.3×	47 0.6×	77 1.0×	47	705
Andrea Henden Australia	9	156 0.8×	256 1.7×	301 2.9×	42 0.5×	128 1.7×	24	540
Sinem Civriz Bozdağ Türkiye	10	114 0.6×	214 1.4×	71 0.7×	17 0.2×	43 0.6×	61	397
Silvy Lachance Canada	15	240 1.3×	331 2.1×	178 1.7×	35 0.5×	118 1.6×	67	616
Odelia Amit Israel	13	278 1.4×	167 1.1×	59 0.6×	48 0.6×	92 1.2×	39	525
Ting‐Ting Han China	15	197 1.0×	399 2.6×	236 2.3×	40 0.5×	71 0.9×	65	676
Ben Carpenter United Kingdom	11	160 0.8×	77 0.5×	128 1.2×	48 0.6×	30 0.4×	28	320

Countries citing papers authored by Joerg Krueger

Since Specialization

Citations

This map shows the geographic impact of Joerg Krueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Krueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Krueger more than expected).

Fields of papers citing papers by Joerg Krueger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Krueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Krueger. The network helps show where Joerg Krueger may publish in the future.

Co-authorship network of co-authors of Joerg Krueger

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Krueger. A scholar is included among the top collaborators of Joerg Krueger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Krueger. Joerg Krueger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

John, Samuel, Kevin J. Curran, Amy K. Keating, et al.. (2025). Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Advances. 9(20). 5249–5262.

Muise, Aleixo M., Karen Frost, Tal Schechter, et al.. (2024). Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease. Transplantation and Cellular Therapy. 30(5). 546.e1–546.e7.

Yates, Bonnie, Seth M. Steinberg, Constance M. Yuan, et al.. (2023). Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure. Transplantation and Cellular Therapy. 29(9). 574.e1–574.e10. 4 indexed citations

Schechter, Tal, et al.. (2023). Intractable abdominal pain as the sole symptom of Varicella Zoster reactivation after allogeneic stem cell transplantation: brief case report and review of the literature. Pediatric Hematology and Oncology. 41(3). 224–228. 1 indexed citations

Krueger, Joerg, et al.. (2023). Image-based recognition of surgical instruments by means of convolutional neural networks. International Journal of Computer Assisted Radiology and Surgery. 18(11). 2043–2049. 1 indexed citations

John, Samuel, Michael Heim, Kevin J. Curran, et al.. (2023). Improved Relapse-Free Survival (RFS) for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Low or Intermediate Preinfusion Disease Burden Treated with Tisagenlecleucel: Results from the CIBMTR Registry. Transplantation and Cellular Therapy. 29(2). S37–S38. 1 indexed citations

Wayne, Alan S., Van Huynh, Nobuko Hijiya, et al.. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 108(3). 747–760. 26 indexed citations

Knight, Tristan, Yubin Ge, Jeffrey W. Taub, Johann Hitzler, & Joerg Krueger. (2021). When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3‐ITD AML. Pediatric Blood & Cancer. 68(11). e29278–e29278. 2 indexed citations

Krueger, Joerg, Johann Hitzler, Mylène Bassal, et al.. (2021). Tisagenlecleucel Therapy Is Safe and Effective for Children with Down Syndrome with ALL in First Relapse. Blood. 138(Supplement 1). 4820–4820. 1 indexed citations

10.

Wall, Donna A. & Joerg Krueger. (2020). Chimeric Antigen Receptor T Cell Therapy Comes to Clinical Practice. Current Oncology. 27(12). 115–123. 24 indexed citations

11.

Cacciotti, Chantel, Muhammad Ali, Ute Bartels, et al.. (2020). Early signs of metabolic syndrome in pediatric central nervous system tumor survivors after high-dose chemotherapy and autologous stem-cell transplantation and radiation. Child s Nervous System. 37(4). 1087–1094. 2 indexed citations

12.

Renzi, Samuele, Joerg Krueger, Kuang‐Yueh Chiang, et al.. (2019). Lymphocyte subset at time of Epstein‐Barr viremia post‐allogeneic hematopoietic stem cell transplantation in children may predict development of post‐transplant lymphoproliferative disease: CD8:CD20 ratio as a sensitive predictor. Pediatric Transplantation. 23(8). e13574–e13574. 5 indexed citations

13.

Wang, Weijia, Hisaki Fujii, Karin G. Hermans, et al.. (2017). Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell–mediated TNFα signaling. Science Translational Medicine. 9(421). 19 indexed citations

14.

Essa, Mohammed Al, Susan E. Richardson, Tal Schechter, et al.. (2015). Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(10). 1802–1807. 47 indexed citations

15.

Lau, Wendy, Adam Gassas, John Doyle, et al.. (2015). Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion. Bone Marrow Transplantation. 50(4). 536–539. 5 indexed citations

16.

Gassas, Adam, Tal Schechter, Joerg Krueger, et al.. (2015). Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(8). 1524–1528. 8 indexed citations

17.

Hauer, Arnaud D., Kim L. L. Habets, Eva J.A. van Wanrooij, et al.. (2008). Vaccination against TIE2 reduces atherosclerosis. Atherosclerosis. 204(2). 365–371. 25 indexed citations

18.

Krueger, Joerg, et al.. (2008). Implementation of a model for identifying Essentially Derived Varieties in vegetatively propagated Calluna vulgaris varieties. BMC Genetics. 9(1). 56–56. 12 indexed citations

19.

Luo, Yunping, He Zhou, Joerg Krueger, et al.. (2006). Targeting tumor-associated macrophages: A novel strategy against breast cancer.. Cancer Research. 66. 1307–1307. 1 indexed citations

20.

Loeffler, Markus, Joerg Krueger, Andreas G. Niethammer, & Ralph A. Reisfeld. (2004). An oral vaccine against the tumor-stromal antigen FAP (fibroblast activation protein) inhibits growth of chemo-resistant murine colon-carcinoma. Cancer Research. 64. 1118–1119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact